Hasten Biopharmaceuticals’ Acquisition of 14 Product Portfolios from Celltrion Healthcare

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition. Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Sapphiros’ Acquisition Of Biocrucible

Mills & Reeve has acted for the majority shareholders of Biocrucible. The acquisition by Sapphiros will provide further investment and operational support to accelerate Biocrucible’s platform...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here